NASDAQ : PCVX
Vaxcyte, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 62.03 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 9.76B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 75.00M | 23.00M | ||||
| Gross Profit | -75.00M | -23.00M | ||||
| Selling, General & Admin | 132.67M | 129.37M | 92.90M | 60.70M | 39.81M | 25.26M |
| Research & Development | 1.03B | 794.31M | 476.64M | 332.34M | 169.45M | 78.41M |
| Operating Expenses | 1.17B | 923.67M | 569.55M | 393.04M | 209.26M | 103.67M |
| Operating Income | -1.17B | -923.67M | -569.55M | -468.04M | -232.26M | -103.67M |
| Interest Expense | -2.00K | -7.00K | ||||
| Interest & Investment Income | 108.08M | 119.72M | 109.99M | 62.91M | 8.36M | 344.00K |
| Currency Exchange Gain (Loss) | 1.67M | |||||
| Other Non Operating Income (Expenses) | -7.05M | 37.33M | -4.38M | 2.87M | 417.00K | 1.58M |
| EBT Excluding Unusual Items | -1.06B | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| Gain (Loss) on Sale of Investments | 2.00K | |||||
| Pretax Income | -1.06B | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| Net Income | -1.06B | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| Net Income to Common | -1.06B | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| Shares Outstanding (Basic) | 139.16M | 136.09M | 122.00M | 97.16M | 64.88M | 51.92M |
| Shares Outstanding (Diluted) | 139.16M | 136.09M | 122.00M | 97.16M | 64.88M | 51.92M |
| EPS (Basic) | -7.65 | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| EPS (Diluted) | -7.65 | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| Free Cash Flow | -921.07M | -712.55M | -571.79M | -364.67M | -176.44M | -127.95M |
| Free Cash Flow Per Share | -6.62 | -5.24 | -4.69 | -3.75 | -2.72 | -2.46 |
| EBITDA | -1.15B | -907.28M | -562.54M | -464.88M | -229.42M | -101.87M |
| D&A For EBITDA | 16.51M | 16.40M | 7.00M | 3.16M | 2.83M | 1.80M |
| EBIT | -1.17B | -923.67M | -569.55M | -468.04M | -232.26M | -103.67M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 183.19M | 173.96M | 387.88M | 397.45M | 834.66M | 68.98M |
| Short-Term Investments | 1.30B | 1.39B | 1.36B | 682.78M | 96.72M | 176.99M |
| Cash & Short-Term Investments | 1.49B | 1.56B | 1.75B | 1.08B | 931.38M | 245.97M |
| Other Receivables | 46.56M | 23.08M | 3.60M | 3.88M | 1.20M | |
| Receivables | 46.56M | 23.08M | 3.60M | 3.88M | 1.20M | |
| Prepaid Expenses | 65.83M | 17.04M | 15.73M | 6.16M | 5.31M | 9.18M |
| Other Current Assets | 2.80M | 1.96M | 5.97M | 1.99M | ||
| Total Current Assets | 1.55B | 1.63B | 1.79B | 1.10B | 942.55M | 256.35M |
| Property, Plant & Equipment | 370.57M | 373.38M | 270.15M | 110.62M | 31.65M | 35.91M |
| Long-Term Investments | 1.02B | 881.66M | 1.39B | 162.68M | 26.55M | 27.12M |
| Long-Term Deferred Charges | 500.00K | |||||
| Other Long-Term Assets | 194.02M | 120.31M | 65.68M | 38.66M | 5.43M | 4.46M |
| Total Assets | 3.14B | 3.00B | 3.51B | 1.41B | 1.01B | 324.34M |
| Accounts Payable | 100.92M | 70.90M | 48.45M | 14.59M | 9.79M | 6.76M |
| Accrued Expenses | 163.85M | 128.72M | 85.84M | 123.64M | 24.82M | 16.68M |
| Current Portion of Leases | 6.51M | 6.12M | 5.89M | 7.11M | 5.91M | 5.28M |
| Total Current Liabilities | 271.28M | 205.75M | 140.18M | 145.34M | 40.52M | 28.72M |
| Long-Term Leases | 108.94M | 111.36M | 65.22M | 22.11M | 12.03M | 11.51M |
| Other Long-Term Liabilities | 100.00K | 100.00K | 9.00K | 96.00K | ||
| Total Liabilities | 380.21M | 317.21M | 205.50M | 167.45M | 52.56M | 40.32M |
| Common Stock | 148.00K | 134.00K | 128.00K | 98.00K | 82.00K | 56.00K |
| Additional Paid-In Capital | 5.53B | 4.84B | 4.70B | 2.16B | 1.48B | 582.84M |
| Retained Earnings | -2.76B | -2.15B | -1.39B | -924.39M | -522.13M | -298.64M |
| Comprehensive Income & Other | -7.55M | 1.59M | -3.87M | 179.00K | -361.00K | -241.00K |
| Total Common Equity | 2.76B | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M |
| Shareholders' Equity | 2.76B | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M |
| Total Liabilities & Equity | 3.14B | 3.00B | 3.51B | 1.41B | 1.01B | 324.34M |
| Total Debt | 115.44M | 117.48M | 71.11M | 29.22M | 17.94M | 16.78M |
| Net Cash (Debt) | 1.37B | 1.44B | 1.68B | 1.05B | 913.43M | 229.19M |
| Net Cash Per Share | 9.85 | 10.61 | 13.74 | 10.82 | 14.08 | 4.41 |
| Filing Date Shares Outstanding | 148.81M | 143.92M | 128.76M | 108.41M | 80.03M | 56.31M |
| Total Common Shares Outstanding | 144.79M | 131.06M | 124.89M | 95.36M | 79.47M | 53.03M |
| Working Capital | 1.28B | 1.42B | 1.65B | 950.62M | 902.03M | 227.63M |
| Book Value Per Share | 19.05 | 20.49 | 26.47 | 13.01 | 12.00 | 5.36 |
| Tangible Book Value | 2.76B | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M |
| Tangible Book Value Per Share | 19.05 | 20.49 | 26.47 | 13.01 | 12.00 | 5.36 |
| Machinery | 65.82M | 58.15M | 35.62M | 15.12M | 11.50M | |
| Construction In Progress | 217.08M | 151.78M | 51.81M | |||
| Leasehold Improvements | 7.24M | 4.38M | 1.46M | 1.35M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -1.06B | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| Depreciation & Amortization | 26.78M | 24.86M | 15.85M | 10.17M | 9.45M | 3.46M |
| Loss (Gain) From Sale of Assets | 97.00K | |||||
| Loss (Gain) From Sale of Investments | -9.32M | -14.43M | -38.70M | -34.77M | -947.00K | 1.41M |
| Stock-Based Compensation | 150.51M | 138.84M | 84.82M | 48.76M | 23.65M | 10.73M |
| Other Operating Activities | 4.93M | -34.77M | 4.23M | 8.00M | ||
| Change in Accounts Payable | 70.83M | 19.91M | 34.58M | 11.22M | 2.90M | -12.47M |
| Change in Other Net Operating Assets | -60.69M | -23.36M | -89.48M | 70.09M | 9.84M | -24.54M |
| Operating Cash Flow | -881.23M | -655.58M | -452.63M | -296.79M | -170.60M | -121.39M |
| Capital Expenditures | -39.84M | -56.97M | -119.16M | -67.88M | -5.84M | -6.55M |
| Sale of Property, Plant & Equipment | 26.00K | |||||
| Investment in Securities | 190.44M | 494.33M | -1.89B | -705.43M | 80.43M | -205.78M |
| Investing Cash Flow | 150.60M | 437.35M | -2.01B | -773.31M | 74.58M | -212.31M |
| Issuance of Common Stock | 622.36M | 13.01M | 2.46B | 643.69M | 862.41M | 17.80M |
| Repurchase of Common Stock | -16.34M | -10.99M | -14.29M | -3.88M | -861.00K | |
| Financing Cash Flow | 606.02M | 2.01M | 2.45B | 639.81M | 861.55M | 17.80M |
| Foreign Exchange Rate Adjustments | 1.20M | 2.44M | 426.00K | -6.69M | 137.00K | -439.00K |
| Net Cash Flow | -123.41M | -213.77M | -9.36M | -436.97M | 765.67M | -316.34M |
| Free Cash Flow | -921.07M | -712.55M | -571.79M | -364.67M | -176.44M | -127.95M |
| Free Cash Flow Per Share | -6.62 | -5.24 | -4.69 | -3.75 | -2.72 | -2.46 |
| Levered Free Cash Flow | -485.76M | -430.85M | -403.44M | -202.41M | -107.53M | -88.16M |
| Unlevered Free Cash Flow | -485.76M | -430.85M | -403.44M | -202.41M | -107.52M | -88.16M |
| Cash Interest Paid | 7.00K | |||||
| Change in Working Capital | 10.13M | -3.45M | -54.90M | 81.32M | 12.74M | -37.01M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.57B | 6.04B | 10.20B | 5.98B | 3.79B | 1.26B |
| Enterprise Value | 8.20B | 4.41B | 8.05B | 4.72B | 3.44B | 978.35M |
| Last Close Price | 62.03 | 46.14 | 81.86 | 62.80 | 47.95 | 23.79 |
| PB Ratio | 3.26 | 2.25 | 3.09 | 4.82 | 3.97 | 4.42 |
| P/TBV Ratio | 3.45 | 2.25 | 3.09 | 4.82 | 3.97 | 4.42 |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.06 |
| Net Debt / Equity Ratio | -0.50 | -0.54 | -0.51 | -0.85 | -0.96 | -0.81 |
| Net Debt / EBITDA Ratio | 1.19 | 1.59 | 2.98 | 2.26 | 3.98 | 2.25 |
| Net Debt / FCF Ratio | 1.49 | 2.03 | 2.93 | 2.88 | 5.18 | 1.79 |
| Quick Ratio | 5.48 | 7.81 | 12.63 | 7.46 | 23.08 | 8.61 |
| Current Ratio | 5.72 | 7.91 | 12.76 | 7.54 | 23.26 | 8.93 |
| Return on Equity (ROE) | -36.51% | -25.59% | -20.41% | -36.67% | -36.12% | -31.78% |
| Return on Assets (ROA) | -22.61% | -17.72% | -14.47% | -24.23% | -21.82% | -18.07% |
| Return on Capital Employed (ROCE) | -40.60% | -33.00% | -16.90% | -37.10% | -24.10% | -35.10% |
| Earnings Yield | -12.58% | -12.69% | -4.55% | -6.73% | -5.90% | -7.97% |
| FCF Yield | -9.68% | -11.80% | -5.60% | -6.10% | -4.66% | -10.19% |
| Buyback Yield / Dilution | -4.88% | -11.55% | -25.57% | -49.75% | -24.95% | -75.73% |